Doxazosin mesylate is the mesylate salt form of doxazosin, a quinazoline compound that selectively blocks alpha-1-adrenergic receptors. This action relaxes smooth muscle in the bladder neck and prostate, reducing obstruction and urethral resistance associated with benign prostate hyperplasia, and also causes vasodilation in peripheral vascular smooth muscle, lowering peripheral vascular resistance.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 77883-43-3
Doxazosin
pharmaceutical raw material
Carisoprodol
pharmaceutical raw material
2-[[1-(2-amino-4-thiazolyl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid
pharmaceutical raw material
Tesevatinib
pharmaceutical raw material
Diclofenac diethylamine
pharmaceutical raw material
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone;methanesulfonic acid
VJECBOKJABCYMF-UHFFFAOYSA-N
COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC.CS(=O)(=O)O